Literature DB >> 20630456

Comparison between the NERS (New Risk Stratification) score and the SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score in outcome prediction for unprotected left main stenting.

Shao-Liang Chen1, Jack P Chen, Gary Mintz, Bo Xu, Jing Kan, Fei Ye, Junjie Zhang, Xuewen Sun, Yawei Xu, Qing Jiang, Aiping Zhang, Gregg W Stone.   

Abstract

OBJECTIVES: This study aimed to compare the NERS (New Risk Stratification) and SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) scores for prognostication after stenting of unprotected left main stenosis in a "real-world" setting.
BACKGROUND: In contrast to existing systems, the NERS score encompasses clinical, procedural, and angiographic characteristics.
METHODS: The NERS score was derived from 260 patients with unprotected left main stenosis who underwent percutaneous coronary intervention and tested in 337 patients in a consecutive left main registry (66.55 +/- 10.49 years, 78.9% men) undergoing percutaneous coronary intervention in a prospective, multicenter trial. Six-month clinical and angiographic follow-up was obtained in 100% and 88.9% of patients, respectively. The primary end point was major adverse cardiac events (MACE), encompassing myocardial infarction, all-cause death, and target vessel revascularization. Receiver-operator characteristic (ROC) curve was generated for the comparison of NERS versus SYNTAX scores.
RESULTS: The NERS score consisted of 54 variables (17 clinical, 4 procedural, and 33 angiographic). A NERS score > or =25 demonstrated a sensitivity and specificity of 92.0% and 74.1% (MACE as state variable), respectively, significantly higher than SYNTAX intermediate risk (20.5% and 25.4%) or SYNTAX higher risk (70.5% and 35.2%, p for all <0.001). At follow-up, myocardial infarction, cardiac death, and target vessel revascularization occurred in 3.0%, 5.6%, and 13.1% of patients, respectively, for a composite MACE of 26.0%. A NERS score > or =25 (hazard ratio: 1.13; 95% confidence interval [CI]: 1.11 to 1.16; p < 0.001) was the only independent predictor of cumulative MACE and stent thrombosis at follow-up (odds ratio: 31.04; 95% CI: 19.36 to 67.07; p < 0.001).
CONCLUSIONS: The NERS score was more predictive of MACE than the SYNTAX score was. Further study is needed to address their relative roles in assessment for appropriateness of coronary artery bypass graft versus percutaneous coronary intervention for unprotected left main coronary artery stenosis. Copyright 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20630456     DOI: 10.1016/j.jcin.2010.04.006

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  18 in total

1.  Combination of angiographic and clinical characteristics for the prediction of clinical outcomes in patients undergoing unprotected left main coronary artery stenting.

Authors:  Jan-Malte Sinning; Viktoria Stoffel; Eberhard Grube; Georg Nickenig; Nikos Werner
Journal:  Clin Res Cardiol       Date:  2012-06       Impact factor: 5.460

2.  Combination of angiographic and clinical characteristics for the prediction of clinical outcomes in elderly patients undergoing multivessel PCI.

Authors:  Jan-Malte Sinning; Tobias Asdonk; Christoph Erlhöfer; Mariuca Vasa-Nicotera; Eberhard Grube; Georg Nickenig; Nikos Werner
Journal:  Clin Res Cardiol       Date:  2013-07-24       Impact factor: 5.460

3.  Incremental prognostic value of the SYNTAX score to late gadolinium-enhanced magnetic resonance images for patients with stable coronary artery disease.

Authors:  Shingo Kato; Naka Saito; Hidekuni Kirigaya; Daiki Gyotoku; Naoki Iinuma; Yuka Kusakawa; Kohei Iguchi; Tatsuya Nakachi; Kazuki Fukui; Masaaki Futaki; Tae Iwasawa; Masataka Taguri; Kazuo Kimura; Satoshi Umemura
Journal:  Heart Vessels       Date:  2015-04-23       Impact factor: 2.037

Review 4.  Novel QCA methodologies and angiographic scores.

Authors:  Vivian G Ng; Alexandra J Lansky
Journal:  Int J Cardiovasc Imaging       Date:  2011-02-20       Impact factor: 2.357

Review 5.  Stenting versus surgery for significant left main disease.

Authors:  Ralf E Harskamp; Duk-Woo Park
Journal:  Curr Cardiol Rep       Date:  2015       Impact factor: 2.931

6.  Stenting of left main coronary artery stenosis: A to Z.

Authors:  Debabrata Dash
Journal:  Heart Asia       Date:  2013-01-25

7.  Balancing Long-Term Risks of Ischemic and Bleeding Complications After Percutaneous Coronary Intervention With Drug-Eluting Stents.

Authors:  Alexis Matteau; Robert W Yeh; Edoardo Camenzind; P Gabriel Steg; William Wijns; Joseph Mills; Anthony Gershlick; Mark de Belder; Gregory Ducrocq; Laura Mauri
Journal:  Am J Cardiol       Date:  2015-06-03       Impact factor: 2.778

8.  Comparison between Exclusive and Selective Drug-Eluting Stent Strategies in Treating Patients with Multivessel Coronary Artery Disease.

Authors:  Ying-Chang Tung; Ping-Gune Hsiao; Lung-An Hsu; Chi-Tai Kuo; Chi-Jen Chang
Journal:  Acta Cardiol Sin       Date:  2014-05       Impact factor: 2.672

9.  Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents in patients with multivessel coronary artery disease compared to coronary artery bypass surgery five-years after intervention.

Authors:  Lisa Krenn; Christoph Kopp; Dietmar Glogar; Irene M Lang; Georg Delle-Karth; Thomas Neunteufl; Gerhard Kreiner; Alexandra Kaider; Jutta Bergler-Klein; Aliasghar Khorsand; Mariam Nikfardjam; Günther Laufer; Gerald Maurer; Mariann Gyöngyösi
Journal:  Catheter Cardiovasc Interv       Date:  2014-02-01       Impact factor: 2.692

10.  Comparison of one-year clinical outcomes between intravascular ultrasound-guided versus angiography-guided implantation of drug-eluting stents for left main lesions: a single-center analysis of a 1,016-patient cohort.

Authors:  Xiao-Fei Gao; Jing Kan; Yao-Jun Zhang; Jun-Jie Zhang; Nai-Liang Tian; Fei Ye; Zhen Ge; Ping-Xi Xiao; Feng Chen; Gary Mintz; Shao-Liang Chen
Journal:  Patient Prefer Adherence       Date:  2014-09-23       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.